SCHEMBL29424136

SCHEMBL29424136

c1cncc(-c2cnc3[nH]cnc3c2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
QPCT Q16769 1/20 0.59
QPCTL Q9NXS2 1/20 0.59
CYP2A6 P11509 6/20 0.51
MAPK1 P28482 2/20 0.50
CYP3A4 P08684 2/20 0.48
ALDH1A1 P00352 1/20 0.48
CYP1A2 P05177 1/20 0.48
PDGFRB P09619 2/20 0.48
PDGFRA P16234 2/20 0.48
EGFR P00533 1/20 0.48
CCNT1 O60563 1/20 0.45
CCNA2 P20248 1/20 0.45
CDK2 P24941 1/20 0.45
CDK9 P50750 1/20 0.45
DYRK1A Q13627 2/20 0.45
NTRK1 P04629 1/20 0.45
PIK3CA P42336 1/20 0.45
CHEK1 O14757 1/20 0.45
CYP2E1 P05181 1/20 0.45
CYP2D6 P10635 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11371088 0.81 PIK3CA (0.56) MAPK1PDGFRBPDGFRAEGFRNTRK1
Hydrochloric Acid SCHEMBL11361979 0.79 PIK3CA (0.53) MAPK1PDGFRBPDGFRAEGFRNTRK1
SCHEMBL6962240 0.77 QPCT (0.77) QPCTQPCTLCYP2A6CYP3A4ALDH1A1
SCHEMBL20791895 0.75 MAP3K11 (0.51) MAPK1CYP3A4CYP1A2CYP2D6CYP2C9
SCHEMBL2979465 0.75 CYP2A6 (0.49) QPCTQPCTLCYP2A6MAPK1CYP3A4
SCHEMBL25937022 0.75 RIPK1 (0.54) DYRK1A
SCHEMBL28442101 0.74 AXL (0.47) CYP2A6MAPK1CYP3A4CYP1A2PIK3CA
SCHEMBL6962245 0.74 QPCT (1.00) QPCTQPCTLCYP2A6MAPK1CYP3A4
SCHEMBL411814 0.74 CDK8 (0.71) CYP2A6MAPK1PDGFRBPDGFRACCNT1
SCHEMBL14395150 0.74 QPCT (0.55) QPCTQPCTLCYP2A6MAPK1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12503477-B2 Colony stimulating factor-1 receptor (CSF-1R) inhibitors GENZYME CORPORATION 2025-12-23 US disclosed
US-20240217991-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS GENZYME CORPORATION (US) 2024-07-04 US disclosed
US-20220396588-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS GENZYME CORPORATION (US) 2022-12-15 US disclosed
CN-114989164-A Substituted 1H-imidazo [4,5-b ] pyridin-2 (3H) -ones and uses thereof 詹森药业有限公司 2022-09-02 CN disclosed
US-11274108-B2 Colony stimulating factor-1 receptor (CSF-1R) inhibitors GENZYME CORPORATION (US) 2022-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11274108-B2 Colony stimulating factor-1 receptor (CSF-1R) inhibitors CSF1R, CSF3R, IL1RN QPCT 2949/4885QPCTL 3720/4885CYP2A6 4743/4885
US-20240217991-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS CSF1R, CSF3R, IL1RN QPCT 2949/4885QPCTL 3720/4885CYP2A6 4743/4885
US-20220396588-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS CSF1R, CSF3R, IL1RN QPCT 2949/4885QPCTL 3720/4885CYP2A6 4743/4885
US-12503477-B2 Colony stimulating factor-1 receptor (CSF-1R) inhibitors CSF1R, CSF3R, IL1RN QPCT 3236/4885QPCTL 3470/4885CYP2A6 4572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.